Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has...
Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement
Katten Enters Miami Market with Prominent Capital Markets Hire from DLA Piper
Katten announced that Josh Kaufman has joined the firm as Managing Partner of Katten’s new Miami office. He will be a partner in the firm’s Capital […]
Province of Santa Fe Issues USD 800 Million Notes Due 2034
DLA Piper has advised the Province of Santa Fe. A&O Shearman has advised the initial purchasers. Bruchou & Funes de Rioja has advised the initial purchasers...
Edenor Completes US$201 Million Senior Notes Reopening
Clifford Chance US LLP and Bruchou & Funes de Rioja have advised the placement agents. DLA Piper Argentina has advised Empresa Distribuidora y Comercializadora Norte S.A....
EDEMSA Issues US$150 Million Senior Step-Up Notes Due 2031
DLA Piper has advised Empresa Distribuidora de Electricidad de Mendoza S.A. (EDEMSA). Clifford Chance US LLP and Bruchou & Funes de Rioja have advised the Initial...
Butterfly Network’s $86.9 Million Common Stock Offering
Foley Hoag advised Butterfly Network, while DLA Piper advised the underwriters on the offering. Butterfly Network, Inc. (NYSE: BFLY), a digital health company, announced the registered...
Elicio Therapeutics’ US$40 Million ATM and US$11.5 Million Public Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Elicio, while DLA Piper advised JonesTrading Institutional Services (Jones), as agent and as sole book-running manager in the...
Zealand Pharma’s US$1 Billion Equity Offering
DLA Piper acted as US counsel to Zealand Pharma on the offering. Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based...
Redx Pharma’s Merger with Jounce Therapeutics
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...